Cellectar Biosciences (CLRB) Common Equity (2010 - 2026)
Cellectar Biosciences (CLRB) posted Common Equity of $29.87 million for Q2 2026, up 390.9% from $6.09 million a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Cellectar Biosciences' Common Equity came in at $8.54 million, down 40.3% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of -31.1% (FY2020 to FY2025).
- In prior years, Cellectar Biosciences' Common Equity was $14.29 million in FY2024, -$15.16 million in FY2023, $8.15 million in FY2022 (-71.9%) and $29.06 million in FY2021 (-47.0%).
- The Q2 2026 figure stands as the highest quarterly Common Equity since Q3 2021.
- On a year-over-year basis, Common Equity increased in 1 of the last five quarters, with growth averaging 43.7%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q1 2024, with growth of 811.8%; the weakest was Q1 2023, with a decline of 94.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Cellectar Biosciences | 22.38 Mn | 22.38 Mn | - | 29.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.87 Mn |
| Dec 31, 2025 | 8.54 Mn |
| Sep 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 6.09 Mn |
| Mar 31, 2025 | 8.25 Mn |
| Dec 31, 2024 | 14.29 Mn |
| Sep 30, 2024 | 15.16 Mn |
| Jun 30, 2024 | 12.38 Mn |
| Mar 31, 2024 | 12.50 Mn |
| Dec 31, 2023 | -15.16 Mn |
| Sep 30, 2023 | -28.00 Mn |
| Jun 30, 2023 | -8.39 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 8.15 Mn |
| Sep 30, 2022 | 10.77 Mn |
| Jun 30, 2022 | 17.91 Mn |
| Mar 31, 2022 | 23.13 Mn |
| Dec 31, 2021 | 29.06 Mn |
| Sep 30, 2021 | 38.59 Mn |
| Jun 30, 2021 | 43.98 Mn |
API Access
Cellectar Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();